Biotechnology Industry in India and it's Regulatory Structure

Mumbai, India (PressExposure) February 19, 2009 -- The global biotechnology industry in 2006 stood at USD73.12 billion up by 15.49% compared to 2005, the industry fared well in terms of fund raising, increased number of alliances and IPOs raised in the same period.Research and development activity, which is the foundation of success for the industry, is receiving continuous support all across the world with total R&D spend contributing to almost 38% of industry revenues.The revenue of the Indian biotechnology industry reached INR85.41billion in 2006-07, up 30.98% from INR 65.21 billion in 2005-06. In 2006-07, top Ten Indian Companies reported revenue of INR 37.74 billion.The biotechnology industry is highly research and development (R&D) intensive.Globally,about 37.9% of revenue is spent on finding and developing new products. Although data relating to biotech R&D in India is not available, anecdotal evidence suggests that major companies are spending considerable amounts on biotech R&D, following their newfound focus on biotechnology.

The Report on indian biotechnology( []) gives information on the core technologies in biotechnology with reference to bio processing,monoclonal antibody,bio-nanotechnology etc. Indian biotechnology report describes major clusters region wise.It provides information on the regulatory bodies and the regulations in biotech industry along with the regulatory structure.It helps in knowing the critical success factors in biotechnology industry with reference to mergers & Acquisitions,product portfolio etc.At the end the report gives a future outlook for biotechnology industry.

Table of Contents :-

3. BIOTECH INDUSTRY – GLOBAL OVERVIEW 3.1 Introduction 3.2 Industry growth 3.2.1 Concentric industry 3.2.2 Industry analysis 3.2.3 Research and development expenditure 3.2.5 Financial flow 3.3 Top ten biotech companies

4.1 Introduction 4.2 Milestones 4.3 The Indian Biotechnology Industry 4.3.1 Size 4.3.2 Industry segments 4.3.3 Exports 4.4 IPOs – Start of a new era 4.4.1 The price of success 4.5 Government Support 4.6 Funding 4.6.1 Government Funding 4.6.2 Private Funding

5. GROWTH DRIVERS 5.1 Introduction 5.2 Positive Regulatory Support 5.3 Availability of finance 5.4 Changing demographics & improved living standards 5.5 Growing Business Community 5.6 Growth of Related Industries 5.7 Knowledge Environment 5.8 Outsourcing

6. MAJOR PLAYERS 6.1 Serum Institute of India 6.2 Biocon 6.3 Panacea Biotech 6.4 Rasi Seeds 6.5 Venkateshwara Hatcheries 6.6 Aventis Pharma Limited 6.7 Glaxo Smithkline Pharmaceuticals 6.8 Shantha Biotechnics 6.9 Bharat Serums and Vaccines 6.10 Wockhardt

7. TECHNOLOGY 7.1 Core technologies 7.1.1 Bioprocessing 7.1.2 Monoclonal antibody 7.1.3 Cell/ tissue culture 7.1.4 Cloning 7.1.5 Recombinant DNA technology 7.1.6 Protein engineering 7.1.7 Biosensors 7.1.8 Bio–Nanotechnology 7.1.9 Microarrays 7.2 Other uses of biotechnology 7.3 Outlook 7.3.1 Pharmacogenomics 7.3.2 Metabolomics 7.3.4 Gene therapy 7.3.5 Immuno (Hybridoma) Technology 7.3.6 Stem cell techniques 7.3.7 Nutraceuticals 7.3.8 Bioremediation 7.3.9 Bioinformatics

For vast information please visit : [] Or Contact us at:

Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website:

About Bharat Book Bureau is your Number ONE source to extensive market research information. We provide market research reports from the world's most reliable publishers and writers. Whether it's a report on the competitive analysis of a new or existing market, or a book providing information about shipping laws, we have a wide range of topics.

Press Release Source:

Press Release Submitted On: February 19, 2009 at 3:34 am
This article has been viewed 26432 time(s).